Cardiologist Carlos Collet takes new leadership role with CRF
The Cardiovascular Research Foundation (CRF) has officially brought in Carlos Collet, MD, PhD, a world-renowned interventional cardiologist and cardiac imaging specialist, as the organization’s new director of cardiovascular imaging, physiology and translational therapeutics.
Collet spent many years as the co-director of the cath lab at OLV Hospitals in Aalst, Belgium. He has also traveled the world advocating for the use of CT-guided interventional procedures and co-authored more than 300 peer-reviewed articles on a wide variety of topics.
In this new role, Collet will be involved in all CRF initiatives going forward. He will provide guidance as the organization continues to prioritize both scientific excellence and innovation.
“I’m honored to join CRF and contribute to its mission of advancing cardiovascular care through innovation, research and education,” Collet said in a statement. “This is a unique opportunity to build on the foundation of excellence already established within the core labs, while expanding our coronary and endovascular imaging capabilities. Together, we will continue to develop new platforms for discovery and deliver more personalized, impactful care to patients around the world.”
“Dr. Collet is a globally recognized expert in coronary CT, a groundbreaking imaging technology that is revolutionizing how we diagnose and treat cardiovascular disease,” added Juan F. Granada, MD, president and chief executive officer of CRF. “His deep expertise will not only ensure strong leadership of our imaging and physiology programs but also drive CRF into new frontiers of innovation reinforcing our position as a global leader in cardiovascular research and care.”
TCT 2025 on the horizon
TCT 2025, CRF’s annual Transcatheter Cardiovascular Therapeutics conference, is scheduled for Oct. 25-28, 2025, at the Moscone Center in San Francisco.
Click here for a full list of late-breaking clinical trials and late-breaking clinical science scheduled for the event. Topics will include percutaneous coronary intervention, transcatheter aortic valve replacement, intravascular lithotripsy, valvular heart disease and much more.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.